STAT Stitch Deep Dive Podcast Beyond The Bedside

STAT Stitch Deep Dive Podcast Beyond The Bedside

by Regular Guy
Season 3

PHARM | Levothyroxine

💊 HIGH-YIELD PHARM REVIEW: LEVOTHYROXINE (Synthroid, Levoxyl, Euthyrox) Levothyroxine sodium is a synthetic T4 thyroid hormone—the body’s inactive form that converts to T3, the active hormone responsible for regulating metabolism, energy use, cardiac output, and CNS development. 🧠❤️ 🔹 Mechanism of Action (MoA): Mimics natural thyroxine (T4) → converted to triiodothyronine (T3) in tissues → restores normal metabolism and energy balance. 🔹 Primary Uses: • Hypothyroidism (all causes) • Myxedema coma (IV form – emergency use) 🔹 Therapeutic Goal: Normalize TSH and T4 → relieve fatigue, weight gain, bradycardia, cold intolerance, and cognitive slowing. ⚠️ Toxicity / Overdose = Hyperthyroidism Symptoms: • Cardiac: Tachycardia, palpitations, arrhythmias, angina, HF, cardiac arrest 🚨 • Neuro: Tremor, insomnia, seizures, anxiety, pseudotumor cerebri • Metabolic: Heat intolerance, weight loss, hyperthermia • Other: Emotional lability, diaphoresis, weakness 👩‍⚕️ Nursing Management & Dosing Pearls • Start low, go slow—especially in older adults or cardiac pts (12.5–25 mcg/day) 💗 • Myxedema coma: IV 200–400 mcg bolus + glucocorticoids to prevent adrenal crisis • Pediatrics: Start with 25% of full dose and titrate weekly to avoid hyperactivity • Never use for weight loss in euthyroid pts ❌ 🍽️ Administration Tips (Oral): • Take on an empty stomach, 30–60 min before breakfast ☀️ • Avoid taking with coffee, fiber, soy, calcium, iron, or antacids—space 4 hours apart • Swallow capsules whole; crush tablets only if allowed and give immediately • Give separately from enteral feedings 💉 IV Administration: • Preferred over IM; reconstitute only with 0.9% NaCl • Stable 4 hours—discard remainder • Push slowly (≤100 mcg/min) via Y-site • IV → PO conversion: increase PO dose by 20–25% ⚠️ Major Drug Interactions (Must-Know!) • Warfarin: ↑ anticoagulant effect → monitor INR closely 🩸 • PPIs, Antacids, Calcium, Iron: ↓ absorption → separate by 4 hrs • Antidiabetics: ↓ glucose control → monitor blood sugars • Amiodarone: may cause hypo- or hyperthyroidism → monitor TSH/T4 • Semaglutide (oral): ↑ T4 exposure by 33% → monitor for hyperthyroid sx 📚 Clinical Pearls: • Absorption: 40–80% (best fasting). • Half-life: ~9–10 days → steady-state 4–6 weeks; re-check TSH after any dose change. • Pregnancy: Safe and essential—dose often ↑ 30–50%; revert postpartum 👶 • Growth: Overuse + GH → early epiphyseal closure in kids. • Gastric Acidity: Required for absorption—watch PPI users! 💡 NCLEX Tip: If a hypothyroid patient reports nervousness, palpitations, or heat intolerance → sign of overdose! Hold dose and notify provider immediately. 🧩 Summary Mnemonic: L-E-V-O = Low → start low dose Early AM on empty stomach Vitals (esp HR) monitor Overdose = hyperthyroid signs 🚨

PHARM | SSRIs-Fluoxetine

💊 HIGH-YIELD SSRI OVERVIEW (80/20 Rule) (Selective Serotonin Reuptake Inhibitors) 🧠 Core Concept: SSRIs ↑ serotonin levels by blocking reuptake in the synaptic cleft — boosting mood, reducing anxiety, and stabilizing emotional regulation. 📋 Top Drugs to Know: Fluoxetine (Prozac) 🌀 Sertraline (Zoloft) 🌊 Escitalopram (Lexapro) 💎 Citalopram (Celexa) 🌤 Paroxetine (Paxil) ⚠️ (sedating, more withdrawal risk) 🩺 Main Indications (What You’ll Actually See): Depression (MDD) Anxiety Disorders (GAD, panic, OCD, PTSD, social anxiety) PMDD & Bulimia (Fluoxetine) Panic Disorder (Sertraline) ⚡️ Mechanism of Action (Simple): Blocks serotonin reuptake pump → serotonin stays longer in the synapse → improved mood & less anxiety. ⏱ Onset: Takes 2–4 weeks for full effect. Educate patients early: “You won’t feel better overnight.” ⚠️ Major Side Effects (Know These Cold): Sexual dysfunction (↓ libido, anorgasmia) GI upset (nausea, diarrhea early on) Insomnia or sedation (drug-dependent) Weight changes (gain with Paroxetine) Headache Serotonin Syndrome 💀 → mental status changes, hyperreflexia, myoclonus, fever, shivering (esp. with MAOIs, St. John’s Wort, or triptans). 👉 Tx: Stop SSRI, give benzodiazepines, supportive care, ± cyproheptadine. 💣 Black Box Warning: ↑ suicidal thoughts in adolescents & young adults (esp. in first few weeks). 🚫 Contraindications & Cautions: MAOIs — must wait 14 days between use → risk of serotonin syndrome. Avoid abrupt discontinuation — causes flu-like withdrawal (esp. Paroxetine). 💉 Nursing Implications: Monitor mood, anxiety, suicidal ideation early in therapy. Educate on delayed effect & adherence. Watch for serotonin syndrome if combined with other serotonergic agents. Encourage taking same time daily. Sertraline often best for patients with cardiac disease (safe profile). 🧩 Clinical Pearls: Fluoxetine = longest half-life (good for poor adherence). Paroxetine = most sedating, highest withdrawal risk. Sertraline = go-to for anxiety & PTSD. Escitalopram = cleanest side effect profile. 🧠 80/20 Takeaway: SSRIs = first-line for depression/anxiety. Know onset delay, serotonin syndrome signs, sexual dysfunction, and black box warning. ⏳ 2–4 weeks to work. Watch early mood shifts. Don’t mix with MAOIs. ✨ Start low, go slow, and monitor the glow (serotonin).

PHARM | SNRIs Venlafaxine

💊 PHARM STUDY GUIDE: VENLAFAXINE Class: SNRI – Serotonin Norepinephrine Reuptake Inhibitor 🧠 Mechanism of Action (MOA): Blocks reuptake of serotonin (5-HT) and norepinephrine (NE) → ↑ levels in synaptic cleft → improved mood & anxiety control. Weak dopamine effect. 📋 Indications: Major Depressive Disorder (MDD) 🧩 Generalized Anxiety Disorder (GAD) 😰 Panic & Social Anxiety Disorders 😳 Off-label: Menopausal hot flashes 🌡 ⚠️ Red-Flag Side Effects (Prioritize 🚨): 1️⃣ Serotonin Syndrome (LIFE-THREATENING) – fever, shivering, agitation, hyperreflexia, rigidity, tachycardia, diarrhea, seizures. 👉 Action: STOP drug, supportive care, cyproheptadine if severe. 2️⃣ Suicidal Ideation – especially in <25 yrs or early therapy. 👉 Action: Monitor mood, report new/worsening depression. 3️⃣ Cardiac Events – ↑ BP, HR, QT prolongation, rare TdP. 👉 Action: Monitor VS, ECG, electrolytes; report chest pain or syncope. 4️⃣ Bleeding Risk – ↓ platelet serotonin → ↑ risk w/ NSAIDs, ASA, anticoagulants. 👉 Action: Monitor for GI bleed, bruising, petechiae. 5️⃣ Hyponatremia/SIADH – elderly or diuretic use. 👉 Action: Monitor Na⁺; report confusion, headache, weakness. 💉 Common Side Effects (Manage): Nausea 🤢, headache, insomnia, constipation, dry mouth, dizziness, sexual dysfunction. Tip: Take w/ food to ↓ GI upset. 🩺 Nursing Interventions: Assess suicidal risk, anxiety, BP, HR regularly. Watch for serotonin syndrome (esp. if on SSRIs, MAOIs, or triptans). Educate: may take 2–4 weeks for full effect. Taper gradually → abrupt stop = withdrawal (dizziness, “brain zaps”). Teach to take same time daily; XR form must be swallowed whole. Avoid alcohol 🍷 → risk of rapid drug release & toxicity. For hepatic/renal impairment → reduce dose 25–50%. 💣 Contraindications & Dangerous Combos: ❌ MAOIs, linezolid, methylene blue → fatal serotonin syndrome. ❌ Other serotonergic drugs (SSRIs, SNRIs, TCAs, tramadol). ❌ QT-prolonging agents (amiodarone, ziprasidone, macrolides). 📊 Pharmacokinetics Highlights: Metabolism: CYP2D6 (major), CYP3A4 (minor). Inhibitors ↑ toxicity risk. Half-life: Venlafaxine 5 h, metabolite (ODV) 11 h. Excretion: Mostly renal → dose adjust if impaired. 🎯 Top 5 High-Yield Takeaways: 1️⃣ Monitor suicidality early & during dose changes. 2️⃣ Never mix with MAOIs or other serotonergic meds. 3️⃣ Swallow XR whole & take with food. 4️⃣ Track BP/ECG & bleeding (esp. if on anticoagulants). 5️⃣ Taper off slowly to avoid severe withdrawal. 🧩 80/20 Rule Summary: 👉 SNRIs like venlafaxine boost serotonin + norepinephrine. Know serotonin syndrome, suicidality, BP/QT risk, bleeding, and withdrawal — that’s 20% of content, 80% of what you’ll be tested on. ⚡️“Start low, go slow, and watch the glow — serotonin can burn hot.”🔥 #PharmNerd 🧠 #EffexorXR #SNRI #NursingSchool #NCLEXPrep #MentalHealth

PHARM | TCAs Amitriptyline

💊 PHARM STUDY GUIDE: AMITRIPTYLINE (Elavil) Class: Tricyclic Antidepressant (TCA) 🧠 MOA (80/20): Blocks neuronal reuptake of serotonin & norepinephrine; also anticholinergic, antihistamine, and sodium-channel effects → efficacy + side-effect burden. NCBI 📋 Indications (what you’ll actually see): Major depressive disorder Off-label, low dose: neuropathic pain, migraine prevention, insomnia (sedating). ⚠️ Red-Flag Side Effects (Prioritize 🚨): Cardiac toxicity – QT prolongation, conduction block, ventricular arrhythmias; overdose can be fatal. Monitor ECG/electrolytes in risk pts. Serotonin syndrome (with MAOIs/serotonergics): fever, agitation, hyperreflexia, diarrhea, tremor, clonus. Stop drug; supportive care; consider cyproheptadine. Anticholinergic crisis – delirium, urinary retention, ileus, hyperthermia (elderly esp.). Orthostatic hypotension & falls (α1-blockade). Suicidality boxed warning in children, adolescents, young adults—highest risk at start & dose changes. 🩺 Nursing Interventions & Monitoring: Baseline & periodic BP/HR, ECG if cardiac risk, electrolyte check (K/Mg) if QT risk. Screen for suicidal ideation early and with any dose change. Watch for anticholinergic effects (bowel regimen, fluids), falls, urinary retention. Assess for drug interactions (see below) and serotonin syndrome. 🚫 Contraindications & Dangerous Combos: MAOIs: contraindicated; 14-day washout (risk of hyperpyrexia/convulsions/SS). Strong CYP2D6 inhibitors (e.g., fluoxetine, paroxetine) ↑ TCA levels → toxicity; avoid or adjust/monitor closely. Additive QT-prolonging meds (amiodarone, macrolides, antipsychotics) → arrhythmia risk. Potentiation with other anticholinergics/CNS depressants (falls, delirium). 🎯 Top 5 High-Yield Takeaways: Powerful but not first-line due to side effects/toxicity—reserve for refractory depression or low-dose pain/migraine. Cardiac safety first: screen QT risks, consider baseline ECG. Night dosing, slow titration, and taper to discontinue. Avoid MAOIs; beware CYP2D6 inhibitors (e.g., fluoxetine). Monitor suicidality, anticholinergic burden, falls, and serotonin syndrome. 🧩 80/20 Summary: Think TCA = reuptake block + anticholinergic + cardiac risk. Safe use = low & slow, night dose, ECG when needed, interaction check, taper, monitor mood & SS.

PHARM | 1st Gen Antipsychotics Haloperidol

💊 PHARM STUDY GUIDE: HALOPERIDOL (Haldol) Class: First-generation antipsychotic 🧠 MOA (80/20): High-potency D2 receptor antagonist → ↓ mesolimbic dopamine (helps positive symptoms). D2 block in other tracts drives side effects. 🧭 Dopamine Pathways (clinical relevance): Mesolimbic: D2 block → ↓ hallucinations/delusions ✅. Nigrostriatal: D2 block → EPS/pseudoparkinsonism ⚠️. Tuberoinfundibular: D2 block → ↑ prolactin (galactorrhea, menstrual changes). 📋 Indications (common): Schizophrenia; acute agitation (IM lactate); Tourette’s tics; long-term adherence with decanoate IM depot (not IV). Some off-label (e.g., delirium) are used with caution. ⚠️ Boxed/Geriatric Warning: Not approved for dementia-related psychosis; ↑ mortality and stroke risk—avoid unless benefits outweigh risks. ❤️ Cardiac Risks: QT prolongation/TdP; risk higher with IV use and high doses; correct K/Mg, monitor ECG, avoid other QT-prolongers. (IV haloperidol is not FDA-approved.) 🔥 Life-Threatening: NMS: fever, rigidity, AMS, autonomic instability → stop drug, ICU care. Severe hematologic/hepatic events (rare) → check CBC/LFTs if symptomatic. 🩺 Common/Important AEs: EPS (akathisia, dystonia, parkinsonism), TD with chronic use; sedation/orthostasis less than many SGAs due to weaker H1/α1 effects. Use AIMS to screen for TD. Treat acute dystonia/akathisia with anticholinergic or dose change. 💊 Formulations & PK pearls: IM lactate: rapid control (peaks ~20–40 min). PO: peaks 2–6 h; bioavailability ~60%. IM decanoate: depot; peak ≈6 days; t½ ≈3 weeks; IM only. Metabolism: hepatic CYP2D6/CYP3A4 → active hydroxyhaloperidol. Poor 2D6 metabolizers: ↑ EPS risk. 🚫 Major Contra/Interactions (high-yield): Avoid with strong QT-prolongers (e.g., pimozide, quinidine; many azoles) → TdP. CYP inhibitors ↑ levels/QT (e.g., ketoconazole + paroxetine combo raised QTc). Ritonavir/fluvoxamine/fluoxetine can elevate levels—consider dose ↓ and ECG. CYP inducers (rifampin, carbamazepine) ↓ levels → relapse risk. Parkinson’s disease: avoid—worsens motor symptoms. 🧑‍⚕️ Nursing/Monitoring: Baseline and periodic ECG, vitals; correct electrolytes. EPS/TD checks (AIMS), fall precautions. Prolactin-related effects counseling. Reassess need regularly in older adults; document non-pharm attempts for BPSD. 🎯 Top 5 NCLEX Takeaways: High-potency D2 blocker → great for positive sx, high EPS/TD risk. QT/TdP risk (esp. IV/high dose) → ECG & avoid QT drugs. Not for dementia psychosis (boxed warning). Decanoate = IM only depot; no IV. Watch for NMS—fever + rigidity = emergency
Season 4

BONUS Compendium Medicine Neurological Assessment and Neurological Disorders

🧠 NEUROLOGY: HIGH-YIELD NURSING STUDY GUIDE ⚡ Your rapid-fire review of the neuro system’s biggest killers and clinical traps. Straight to the point, loaded with red flags 🚨, and built for real-world nursing. 🩸 TRAUMATIC BRAIN INJURY (TBI) & ICP Mild TBI: GCS ≥13, LOC <30 min. 90% of all neurotrauma. Moderate–Severe TBI: GCS ≤12. Watch for Cushing’s Triad (↑BP, ↓HR, irregular respirations). ➤ ATLS protocol, maintain perfusion, give mannitol or hypertonic saline. Epidural Hematoma: ⚠️ Lucid interval, then coma. Ipsilateral dilated pupil → emergency craniectomy. Subdural Hematoma: Often venous. Elderly/anticoagulated high risk. Treat with surgical decompression. Herniation: Brain shift due to ↑ICP—uncal herniation = blown pupil + contralateral weakness. ➤ Mannitol, hyperventilation, surgical decompression. 🧬 CEREBROVASCULAR DISORDERS Ischemic Stroke: 🕒 Time = Brain. Sudden neuro deficit (aphasia, hemiparesis, vision loss). ➤ IV rtPA (alteplase) within 4.5 h if no contraindications. Mechanical thrombectomy up to 24 h. Hemorrhagic Stroke: Headache, vomiting, ↓LOC. Often hypertensive or aneurysmal. ➤ Reverse anticoagulation, control BP, consider surgical evacuation. NPH (Normal Pressure Hydrocephalus): Hakim’s Triad — gait instability, dementia, incontinence. 🦠 CNS INFECTIONS & SEIZURES Bacterial Meningitis: Fever, neck stiffness, photophobia, ↓LOC. Petechial rash = meningococcal sepsis 🚨 ➤ Dexamethasone IV → then ABX, isolate, monitor for sepsis & hydrocephalus. Viral Encephalitis (HSV): Hallucinations, confusion → IV Acyclovir STAT. Status Epilepticus: Seizure >5 min = neuro emergency. ➤ 1st: Midazolam/Lorazepam IV → 2nd: repeat → 3rd: Phenytoin/Valproic/Levetiracetam. Absence Seizures: 5–10 sec “blank stares,” often in kids. Provoked by hyperventilation. Todd Paresis: Transient weakness after seizure (mimics stroke). 🧍‍♀️ DIAGNOSTIC & NURSING CRITICALS GCS: Eye, Verbal, Motor — use highest side score. Pupils: Dilated + unreactive = herniation or EDH ⚡ Headache Red Flags: Sudden severe onset, fever, neuro deficit, morning vomiting, age >50. Lumbar Puncture: Flat 1–4 h post-procedure. ❌Contraindicated w/ ↑ICP (risk of herniation). CT/MRI: CT = first-line for TBI/SAH. MRI contraindicated in metal implants or unstable pts. 💉 CRITICAL LABS & DRUG MONITORING Bacterial CSF: ↑Pressure, ↑WBC (neutrophils), ↑Protein, ↓Glucose, cloudy. Viral CSF: Normal glucose, lymphocytes, clear. Post-Thrombolysis Bleed Risk: Major complication of rtPA. Anticoag Monitoring:Warfarin → INR Heparin → aPTT LMWH → anti-Xa

PEDI | Development of the Infant P2

Physical Growth and Vital Signs Infancy involves rapid physical maturation. Newborns may lose up to 10% of their birth weight but regain it by 10 to 14 days,. Weight doubles by 4 to 6 months and triples by 1 year,. Height increases by approximately 50% by 12 months, and head circumference increases rapidly to reflect brain growth,. The posterior fontanel closes by 2 months, while the anterior closes by 12 to 18 months. Vital Signs by Age: • Heart Rate: Newborn (110–160/min); Infant (90–160/min). • Respirations: Newborn (30–60/min); Infant (25–60/min). • Blood Pressure (Average): Newborn (64/41 mm Hg); Infant (85/50 mm Hg). • Temperature: Ranges from 37.5°C (99.5°F) at 3 months to 37.7°C (99.9°F) at 1 year (axillary/rectal routes preferred). Pain Assessment: Nurses should use age-appropriate tools like the CRIES scale for neonates (assessing crying, oxygen requirement, vital signs, expression, and sleeplessness). For infants 2 months to 7 years, the FLACC scale (Face, Legs, Activity, Cry, Consolability) is used. Developmental Stages and Theories Development proceeds in a cephalocaudal (head-to-toe) and proximodistal (center-to-outward) pattern. For premature infants, developmental milestones and growth are assessed using their adjusted age (chronological age minus weeks premature),. • Psychosocial (Erikson): Trust vs. Mistrust. Caregivers must meet needs promptly to foster trust; delayed gratification is learned over time,. • Cognitive (Piaget): Sensorimotor Stage. Infants progress from reflexes to purposeful acts. Key achievements include Object Permanence (realizing objects exist when unseen, around 9 months) and mental representation,. • Social/Emotional: Separation anxiety begins around 4–8 months, and stranger fear becomes evident between 6–8 months,. Key Motor Milestones: • 2 Months: Holds head up when prone; social smile,. • 4 Months: Rolls from back to side; holds head steady; places objects in mouth,. • 6 Months: Rolls from back to front; sits with support (tripod); holds bottle,. • 9 Months: Sits unsupported; pulls to stand; uses crude pincer grasp,. • 12 Months: Walks with one hand held or cruises; sits from standing; uses fine pincer grasp,. Sleep and Dental: Infants should sleep on a firm mattress in the supine (back) position to prevent SIDS,. Teething typically begins between 6 to 10 months; clean teeth with a cool, wet washcloth. Safety: • Car Seats: Rear-facing in the back seat at a 45-degree angle,. • Home: Cover outlets, use safety gates, set water heater <49°C, and avoid small choking hazards (grapes, coins, candy),. Immunization Schedule (0 to 12 Months) The CDC recommends the following schedule for healthy infants: • Birth: Hepatitis B (Hep B). • 2 Months: DTaP, Rotavirus (RV), IPV (Polio), Hib, PCV (Pneumococcal), Hep B. • 4 Months: DTaP, RV, IPV, Hib, PCV. • 6 Months: DTaP, IPV, PCV, Hep B, RV, Hib. • 6 to 12 Months: Seasonal Influenza vaccination (yearly)

PEDI | Teens P2

Adolescent Growth and Development • Physiologic Changes: Puberty is driven by the hypothalamus releasing GnRH, stimulating the pituitary to release FSH and LH, which triggers gonadal response (estrogen in females, testosterone in males). Females generally enter puberty (ages 9–10) and reach physical maturity before males. A distinct growth spurt occurs, with females gaining 15–55 lbs and males gaining 15–65 lbs during this period. Organ systems mature, resulting in increased respiratory volume and blood volume, while the basal metabolic rate reaches adult levels. • Cognitive Development (Piaget): Adolescents enter the Formal Operations stage. Early adolescence involves limited abstract thought, while middle and late adolescence (14–20 years) see the development of abstract thinking, deductive reasoning, future planning, and the ability to think outside the present. • Psychosocial Development (Erikson): The primary task is Identity vs. Role Confusion. Adolescents strive to develop a sense of self and autonomy separate from parents. Peer groups become the essential source of support and identity validation, often leading to conflict with parents and a focus on conformity to peer norms. • Health Promotion: Adolescents require increased calories, zinc, calcium (1,300 mg/day), and iron to support rapid growth. They ideally need 9 hours of sleep per night, though biological shifts often cause them to stay awake later. Safety is a major concern due to feelings of invincibility; motor vehicle crashes are the leading cause of unintentional injury death, followed by poisoning and drowning. Suicide is the third leading cause of death in this age group. Vital Signs (Adolescents 13–18 Years) The expected physiological ranges for this age group approach adult values: • Temperature: Approximately 36.6° C (97.9° F) via oral, axillary, or tympanic routes. • Pulse Rate: 50 to 100 beats/minute. • Respirations: 16 to 20 breaths/minute. • Blood Pressure: Systolic less than 120 mmHg; Diastolic less than 80 mmHg. • Pain Assessment: The Numeric Scale (0–10) is the standard tool for self-reporting pain in children 5 years and older. The FACES scale (0–5 or 0–10) may also be used. Immunization Schedule (7–18 Years) The CDC recommends the following vaccines specifically for adolescents, assuming the childhood primary series was completed. Routine Vaccinations at 11–12 Years: • Tdap (Tetanus, diphtheria, and acellular pertussis): 1 dose is routinely administered at 11–12 years. • HPV (Human papillomavirus): Routinely recommended at 11–12 years (can start at age 9). If started before age 15, it is a 2-dose series (0, 6–12 months). If started at age 15 or older, it is a 3-dose series (0, 1–2, 6 months). • Meningococcal ACWY (MenACWY): 1st dose at 11–12 years, with a booster dose recommended at 16 years. Routine Annual Vaccination: • Influenza: 1 dose annually for all adolescents. Catch-up and Risk-Based Vaccinations: • Meningococcal Serogroup B (MenB): Recommended based on shared clinical decision-making for adolescents ages 16–23 (preferred 16–18 years), or for those at increased risk (e.g., asplenia). • Dengue: Recommended for ages 9–16 years living in endemic areas with laboratory confirmation of previous dengue infection. • Catch-up: Adolescents with incomplete histories should receive catch-up doses for Hepatitis B, Hepatitis A, Poliovirus (IPV), MMR, and Varicella.

PEDI | Atraumatic Care P2

Core Definition and The Three Principles Atraumatic care is defined as therapeutic care that minimizes or eliminates the psychological and physical distress experienced by children and their families within the health care system. Rooted in the premise of "do no harm," this approach relies on three fundamental principles: 1. Preventing or minimizing physical stressors: This includes avoiding pain, sleeplessness, and bodily injury. Nurses should utilize pharmacological interventions and comfort positions, such as "therapeutic hugging" (holding the child securely to prevent movement without forceful restraint), rather than "holding down" a child. 2. Preventing or minimizing child-family separation: Recognizing the family as the patient, nurses must support family-centered care and allow parents to stay with their children during procedures whenever possible. 3. Promoting a sense of control: Hospitalization often induces helplessness; nurses can counter this by respecting home routines, allowing choices (e.g., which juice to drink), and fostering a partnership where the child and family actively participate in care. Therapeutic Communication and Psychological Safety Effective interaction is vital for reducing anxiety and is dictated by the child's developmental stage. • Developmental Approaches: Infants rely on touch and tone, while toddlers and preschoolers require simple, concrete language and play. School-age children benefit from explanations and being allowed to ask questions, whereas adolescents require privacy, confidentiality, and respect for their independence. • Language Selection: Nurses must avoid medical jargon that can be misinterpreted (e.g., using "special kind of sleep" instead of "put to sleep" to avoid fear of death, or "tube" instead of "catheter"). • The Child Life Specialist (CLS): These professionals are essential for "high-value" care; they provide nonmedical preparation for surgeries, facilitate therapeutic play (an emotional outlet for stress), and act as advocates to foster the child’s well-being. Utilizing a CLS is considered an indicator of excellence in pediatric care. Family-Centered Care and Cultural Competence Family-centered care acknowledges that the family is the constant in a child's life and the primary source of strength. It requires a partnership based on respect, information sharing, and collaboration. • Cultural Humility: Nurses must identify who the decision-makers are and respect cultural practices. • Language Access: When a family does not speak English, trained interpreters are essential; family members should not be used as interpreters to prevent medical errors and maintain confidentiality. • Assessment: Before teaching, nurses must assess learning styles, literacy levels, and barriers such as language or pain. • Developmental Teaching: Toddlers should be told about procedures immediately beforehand to prevent anxiety, while school-age children can be prepared days in advance. Procedural Preparation and Support Preparation is key to minimizing trauma. • Before: Explain what will happen using sensory details (what the child will hear, see, or feel) to lower anxiety. • During: Use distraction (blowing bubbles, singing) and parental support rather than restraint. • After: Encourage medical play (using puppets or dolls) to allow the child to express feelings, and offer praise for their cooperation

PEDI | Safety and Development of the Toddler

Toddlers typically gain 3 to 5 pounds and grow 3 inches in height per year. By age 2, they attain approximately half of their adult height, and the anterior fontanel closes by 18 months. Vital Signs (Ages 1–3 Years): • Temperature: Ranges from 37.7°C (99.9°F) at 1 year to 37.2°C (99.0°F) at 3 years. • Pulse: 80 to 140 beats/min. • Respirations: 25 to 30 breaths/min. • Blood Pressure (1–2 years): ◦ Male: Systolic 85–91, Diastolic 37–46. ◦ Female: Systolic 86–89, Diastolic 40–49. • Pain Assessment: The FLACC scale (Face, Legs, Activity, Cry, Consolability) is used for children aged 2 months to 7 years. Developmental Stages Psychosocial (Erikson): The toddler enters the stage of Autonomy vs. Shame and Doubt. This period is marked by the child's desire to exert control, often leading to negativism (the consistent use of "no") and temper tantrums as they struggle between dependence and independence. Cognitive (Piaget): • Sensorimotor (12–24 months): Toddlers engage in tertiary circular reactions, experimenting with behaviors and developing object permanence. • Preoperational (2–7 years): Characteristics include animism (attributing lifelike qualities to objects), domestic mimicry (imitating household tasks), and symbolic thought. Motor and Language Milestones: • Gross Motor: Toddlers walk independently by 15–18 months. By 24 months, they can kick a ball and walk up stairs; by 30 months, they jump with both feet. • Fine Motor: Skills progress from using a spoon at 15 months to turning doorknobs at 30 months and copying a circle by 36 months. • Language: Receptive language (understanding) develops faster than expressive language. Speech evolves from single words ("mama/dada") at 15 months to telegraphic speech (2-3 word sentences like "want cookie") by 24 months. Social and Safety: Play is primarily parallel play, where toddlers play alongside but not with other children. Safety is a priority due to increasing mobility; hazards include poisoning, drowning, and burns. Car seats should remain rear-facing until at least age 2 or until the child meets the manufacturer's height/weight requirements. Vaccination Schedule (12 Months – 3 Years) The CDC recommends the following immunization schedule for this age group: • 12 to 15 Months: ◦ Hib (Haemophilus influenzae type b): Booster dose. ◦ PCV (Pneumococcal conjugate): Dose 4. ◦ MMR (Measles, mumps, rubella): Dose 1. ◦ VAR (Varicella): Dose 1. ◦ HepA (Hepatitis A): Dose 1 (routine vaccination is a 2-dose series between 12–23 months, separated by at least 6 months). • 15 to 18 Months: ◦ DTaP (Diphtheria, tetanus, acellular pertussis): Dose 4. • 6 to 18 Months (Range): ◦ HepB (Hepatitis B): Dose 3 (must be at least 24 weeks of age). ◦ IPV (Inactivated poliovirus): Dose 3. • Annual: ◦ Influenza: 1 or 2 doses annually depending on vaccination history
7 of 34